---
category: news
title: "Roivant extends AI drug discovery reach with $450M Silicon Therapeutics buyout"
excerpt: "Roivant Sciences is expanding its drug discovery and design capabilities via a stock deal to acquire Silicon Therapeutics. The Boston startup uses physics-based modeling to simulate proteins and the small molecules that bind to them."
publishedDateTime: 2021-02-26T20:35:00Z
originalUrl: "https://medcitynews.com/2021/02/roivant-extends-ai-drug-discovery-reach-with-450m-silicon-therapeutics-buyout/"
webUrl: "https://medcitynews.com/2021/02/roivant-extends-ai-drug-discovery-reach-with-450m-silicon-therapeutics-buyout/"
type: article
quality: 33
heat: -1
published: false

provider:
  name: MedCity News
  domain: medcitynews.com

topics:
  - AI

images:
  - url: "https://medcitynews.com/uploads/2021/02/GettyImages-1093880948.jpg"
    width: 724
    height: 483
    isCached: true

related:
  - title: "Roivant Dives Deeper into AI with Silicon Therapeutics Purchase"
    excerpt: "Roivant Sciences, the umbrella company for Vivek Ramaswamy’s series of ‘vant companies, acquired Silicon Therapeutics for $450 million in Roivant equity."
    publishedDateTime: 2021-02-26T16:05:00Z
    webUrl: "https://www.pharmalive.com/roivant-dives-deeper-into-ai-with-silicon-therapeutics-purchase/"
    type: article
    provider:
      name: PharmaLive
      domain: pharmalive.com
    quality: 39
    images:
      - url: "https://www.pharmalive.com/wp-content/uploads/2021/02/Roivant-Dives-Deeper-into-AI-with-450-Million-Buy-of-Silicon-Therapeutics-BioSpae-2-26-21.jpeg"
        width: 625
        height: 350
        isCached: true

secured: "p9WYOSyYJGwGOtK0M2nou0znOnz+zrqxHJMJq4hbF1+lUhuGwwvd6IZP0wtfUxVCuiJSbZOq+hW+++Eglq6IYX8swn7SUGNk3TTljjzrhhr/fBVfY960k4ol8zG91KojDZBYzyRB6MPp1Dva9nANa2g8J8eN2A6I+zzvB7QWV/FTm6dLy00OUa32NOH4ijJhCTFBNrvw36ae8/dWTQ6RWG3QxgQT4QYYj/PKETMoFy8cM+2yzJGUVhMstA9GZhQ8mG1yIN1c9S0EjF+2iVI7kcgMTc/SDPv9l7vMuYDxNymPLImwd6sTKAUnmNrGlVqNDh1Z0K7qbi0aWBNJmessIJeKRgHOjaOHaMFzoHIoTSk=;SDEGxgkydXQZXzHmv7/HPg=="
---

